Braidwell
Latest statistics and disclosures from Braidwell's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Guardant Health, CAI, Novocure, XENE, CGON, and represent 29.51% of Braidwell's stock portfolio.
- Added to shares of these 10 stocks: SLNO (+$87M), Novocure (+$70M), ACAD (+$51M), HNGE (+$45M), CVS (+$33M), DNTH (+$33M), CDNA (+$32M), BMRN (+$29M), INSP (+$27M), THC (+$25M).
- Started 25 new stock positions in FULC, ENGN, AKRO, DNTH, HNGE, RARE, THC, DRUG, CDNA, RNA.
- Reduced shares in these 10 stocks: ARGX (-$87M), ADPT (-$47M), GH (-$44M), NBIX (-$39M), KRYS (-$37M), ATEC (-$31M), HROW (-$26M), LEGN (-$23M), SION (-$23M), APLS (-$19M).
- Sold out of its positions in Alphatec Holdings, APLS, CELC, GH, MDGL, UNH, CBIO.
- Braidwell was a net buyer of stock by $162M.
- Braidwell has $3.4B in assets under management (AUM), dropping by 15.27%.
- Central Index Key (CIK): 0001920938
Tip: Access up to 7 years of quarterly data
Positions held by Braidwell consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Braidwell
Braidwell holds 73 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Guardant Health Debt 1.250% 2/1 (Principal) | 8.5 | $286M | 220M | 1.30 |
|
|
| Caris Life Sciences (CAI) | 6.6 | $221M | 7.3M | 30.25 |
|
|
| Novocure Note 11/0 (Principal) | 6.2 | $210M | +50% | 211M | 0.99 |
|
| Xenon Pharmaceuticals (XENE) | 4.3 | $145M | 3.6M | 40.15 |
|
|
| Cg Oncology (CGON) | 3.9 | $132M | 3.3M | 40.28 |
|
|
| Neurocrine Biosciences (NBIX) | 3.7 | $124M | -24% | 880k | 140.38 |
|
| Repligen Corp Note 1.000%12/1 (Principal) | 3.0 | $102M | 101M | 1.01 |
|
|
| Krystal Biotech (KRYS) | 2.7 | $92M | -28% | 520k | 176.53 |
|
| Nuvalent Inc-a (NUVL) | 2.6 | $88M | -13% | 1.0M | 86.48 |
|
| Neogenomics Note 0.250% 1/1 (Principal) | 2.6 | $87M | 100M | 0.86 |
|
|
| Soleno Therapeutics (SLNO) | 2.6 | $87M | NEW | 1.3M | 67.60 |
|
| Irhythm Technologies Note 1.500% 9/0 (Principal) | 2.5 | $85M | -11% | 62M | 1.38 |
|
| Edgewise Therapeutics (EWTX) | 2.5 | $85M | 5.2M | 16.22 |
|
|
| Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal) | 2.2 | $73M | -11% | 82M | 0.89 |
|
| Inspire Med Sys (INSP) | 1.9 | $66M | +69% | 884k | 74.20 |
|
| Glaukos (GKOS) | 1.9 | $64M | +29% | 780k | 81.55 |
|
| Danaher Corporation (DHR) | 1.8 | $61M | 309k | 198.26 |
|
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.8 | $60M | -28% | 1.8M | 32.61 |
|
| Intuitive Surgical Com New (ISRG) | 1.7 | $58M | +45% | 130k | 447.23 |
|
| Apogee Therapeutics (APGE) | 1.7 | $57M | -2% | 1.4M | 39.73 |
|
| Argenx Se Sponsored Adr (ARGX) | 1.7 | $56M | -60% | 76k | 737.56 |
|
| Thermo Fisher Scientific (TMO) | 1.6 | $55M | -15% | 114k | 485.02 |
|
| Align Technology (ALGN) | 1.5 | $51M | -17% | 410k | 125.22 |
|
| ACADIA Pharmaceuticals (ACAD) | 1.5 | $51M | NEW | 2.4M | 21.34 |
|
| Hinge Health Cl A (HNGE) | 1.3 | $45M | NEW | 911k | 49.08 |
|
| Spyre Therapeutics Com New (SYRE) | 1.3 | $43M | 2.6M | 16.76 |
|
|
| Transmedics Group (TMDX) | 1.2 | $39M | +37% | 351k | 112.20 |
|
| Irhythm Technologies (IRTC) | 1.2 | $39M | -24% | 226k | 171.99 |
|
| Penumbra (PEN) | 1.1 | $36M | +9% | 142k | 253.32 |
|
| Karyopharm Therapeutics Note 6.000% 5/1 (Principal) | 1.0 | $35M | 49M | 0.72 |
|
|
| Dyne Therapeutics (DYN) | 1.0 | $35M | -16% | 2.7M | 12.65 |
|
| CVS Caremark Corporation (CVS) | 1.0 | $33M | NEW | 439k | 75.39 |
|
| Dianthus Therapeutics (DNTH) | 1.0 | $33M | NEW | 835k | 39.35 |
|
| Caredx (CDNA) | 0.9 | $32M | NEW | 2.2M | 14.54 |
|
| BioMarin Pharmaceutical (BMRN) | 0.8 | $29M | NEW | 528k | 54.16 |
|
| Globus Med Cl A (GMED) | 0.8 | $29M | +101% | 498k | 57.27 |
|
| Oruka Therapeutics (ORKA) | 0.8 | $27M | -9% | 1.4M | 19.23 |
|
| Repligen Corporation (RGEN) | 0.8 | $26M | +35% | 196k | 133.67 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.7 | $25M | -41% | 643k | 38.83 |
|
| Tenet Healthcare Corp Com New (THC) | 0.7 | $25M | NEW | 122k | 203.04 |
|
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.7 | $24M | 8.4M | 2.87 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.7 | $23M | NEW | 415k | 54.71 |
|
| Akero Therapeutics (AKRO) | 0.7 | $23M | NEW | 475k | 47.48 |
|
| Alphatec Hldgs Com New (ATEC) | 0.7 | $22M | -58% | 1.5M | 14.54 |
|
| Orthopediatrics Corp. (KIDS) | 0.6 | $21M | 1.1M | 18.53 |
|
|
| Viking Therapeutics (VKTX) | 0.6 | $20M | -47% | 760k | 26.28 |
|
| Castle Biosciences (CSTL) | 0.6 | $19M | 823k | 22.77 |
|
|
| Bright Minds Biosciences Com New (DRUG) | 0.5 | $18M | NEW | 304k | 60.66 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $18M | NEW | 589k | 30.08 |
|
| Harrow Health (HROW) | 0.5 | $17M | -60% | 342k | 48.18 |
|
| Sarepta Therapeutics (SRPT) | 0.5 | $16M | NEW | 832k | 19.27 |
|
| Kymera Therapeutics (KYMR) | 0.5 | $16M | NEW | 277k | 56.60 |
|
| Engene Holdings (ENGN) | 0.5 | $16M | NEW | 2.3M | 6.83 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.5 | $15M | 2.2M | 7.05 |
|
|
| Celldex Therapeutics Com New (CLDX) | 0.5 | $15M | NEW | 592k | 25.87 |
|
| Xencor (XNCR) | 0.4 | $15M | -24% | 1.2M | 11.73 |
|
| Avidity Biosciences Ord (RNA) | 0.4 | $15M | NEW | 332k | 43.57 |
|
| Encompass Health Corp (EHC) | 0.4 | $14M | NEW | 113k | 127.02 |
|
| Vera Therapeutics Cl A (VERA) | 0.4 | $14M | NEW | 473k | 29.06 |
|
| Neogenomics Com New (NEO) | 0.4 | $14M | NEW | 1.8M | 7.72 |
|
| Dexcom Note 0.250%11/1 (Principal) | 0.4 | $13M | -27% | 14M | 0.99 |
|
| Tectonic Therapeutic (TECX) | 0.3 | $12M | NEW | 737k | 15.69 |
|
| Replimune Group (REPL) | 0.3 | $12M | +550% | 2.8M | 4.19 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.3 | $11M | -80% | 736k | 14.96 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.3 | $11M | 2.5M | 4.33 |
|
|
| Sionna Therapeutics (SION) | 0.3 | $9.2M | -70% | 314k | 29.41 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.2 | $8.3M | NEW | 613k | 13.59 |
|
| Royalty Pharma Shs Class A (RPRX) | 0.2 | $6.4M | NEW | 182k | 35.28 |
|
| Immunocore Hldgs Note 2.500% 2/0 (Principal) | 0.2 | $6.2M | -74% | 6.8M | 0.91 |
|
| Fulcrum Therapeutics (FULC) | 0.1 | $2.0M | NEW | 220k | 9.20 |
|
| Surrozen Com New (SRZN) | 0.1 | $1.8M | 140k | 12.88 |
|
|
| Heartflow Inc/Sh | 0.0 | $1.7M | NEW | 50k | 33.66 |
|
| Pulmonx Corp (LUNG) | 0.0 | $1.2M | 753k | 1.62 |
|
Past Filings by Braidwell
SEC 13F filings are viewable for Braidwell going back to 2022
- Braidwell 2025 Q3 filed Nov. 14, 2025
- Braidwell 2025 Q2 filed Aug. 14, 2025
- Braidwell 2025 Q1 filed May 15, 2025
- Braidwell 2024 Q4 filed Feb. 14, 2025
- Braidwell 2024 Q3 filed Nov. 14, 2024
- Braidwell 2024 Q2 filed Aug. 14, 2024
- Braidwell 2024 Q1 filed May 15, 2024
- Braidwell 2023 Q4 filed Feb. 14, 2024
- Braidwell 2023 Q3 filed Nov. 14, 2023
- Braidwell 2023 Q2 filed Aug. 14, 2023
- Braidwell 2023 Q1 filed May 15, 2023
- Braidwell 2022 Q4 filed Feb. 14, 2023